ImmunoPrecise Antibodies Ltd. (IPA): Price and Financial Metrics
IPA Price/Volume Stats
Current price | $0.39 | 52-week high | $2.60 |
Prev. close | $0.41 | 52-week low | $0.35 |
Day low | $0.37 | Volume | 167,300 |
Day high | $0.41 | Avg. volume | 349,993 |
50-day MA | $0.55 | Dividend yield | N/A |
200-day MA | $1.04 | Market Cap | 11.13M |
IPA Stock Price Chart Interactive Chart >
ImmunoPrecise Antibodies Ltd. (IPA) Company Bio
ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, Europe, and internationally. Its services include B cell sorting, screening and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multispecies antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, and characterization and validation; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with screening and clone-picking; cryopreservation; affinity measurements, functional assays, and epitope mapping and binning; and modeling, design, and manufacturing of custom antigen. The company has a collaboration with University of Victoria to develop a saliva-based antibody-based test for the detection and screening of COVID-19; Zymeworks Inc. for the development of multiple antibody candidates to fight COVID-19; and National Research Council of Canada's Human Health Therapeutics Research Centre to develop neutralizing PolyTope antibodies against SARS-CoV-2, as well as a research partnership with Mila. ImmunoPrecise Antibodies Ltd. was founded in 1989 and is headquartered in Fargo, North Dakota.
IPA Price Returns
1-mo | -23.11% |
3-mo | -51.85% |
6-mo | -64.86% |
1-year | -70.45% |
3-year | -92.72% |
5-year | N/A |
YTD | -77.19% |
2023 | -67.18% |
2022 | -2.80% |
2021 | -64.15% |
2020 | 579.08% |
2019 | N/A |
Loading social stream, please wait...